NCT00082602 – Galantamine ER Open Label Rapid Dose Escalation Trial in Alzheimer’s Disease Posted on September 20, 2017 by tsuperadmin -
Attainment of treatment goals by people with Alzheimer’s disease receiving galantamine: a randomized controlled trial Posted on September 7, 2017 by tsuperadmin -
NCT00645190 – A Randomized, Double Blind, Active Control, Flexible Dose, Multicenter Study to Evaluate Galantamine HBr in the Treatment of Alzheimer’s Disease: Safety and Effectiveness of an Immediate-release Table Formulation. Posted on September 7, 2017 by tsuperadmin -
NCT02136134 – Phase 3 Study Comparing Daratumumab, Bortezomib and Dexamethasone (DVd) vs Bortezomib and Dexamethasone (Vd) in Subjects With Relapsed or Refractory Multiple Myeloma Posted on September 7, 2017 by tsuperadmin -
NCT02076009 – Phase 3 Study Comparing Daratumumab, Lenalidomide, and Dexamethasone (DRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed or Refractory Multiple Myeloma Posted on September 7, 2017 by tsuperadmin -
NCT02113579 – Assessment of potassium oxalate containing formulation for the relief of dentinal hypersenstivity Posted on August 31, 2017 by tsuperadmin -
NCT01727258 – Evaluation of an experimental mouth rinse device for relieving dentinal hypersenstivity Posted on August 31, 2017 by tsuperadmin -
NCT01345292 – Assessment of a potassium oxalate containing formulation for the relief of dentinal sensitivity Posted on August 31, 2017 by tsuperadmin -
NCT01156376 – Determination of the oral irritation and sensitization potential of two experimental potassium oxalate containing mouth rinses Posted on August 31, 2017 by tsuperadmin -
NCT01226459 – A Phase 3, Multi-Center, Parallel Design Clinical Trial to Compare the Efficacy and Safety of 5% Minoxidil Foam versus vehicle in Females for the Treatment of Female Pattern Hair Loss (Androgenetic Alopecia) Posted on August 31, 2017 by tsuperadmin -
The YODA Project